Cancer care gets go-ahead

Published date13 April 2024
Publication titleHuddersfield Daily Examiner
A charity described the decision by the National Institute for Health and Care Excellence (Nice) as a "ray of hope" for patients with few other options

Tisagenlecleucel, sold under the brand name Kymriah, is a Car-T therapy, a personalised treatment which reprogrammes a patient's immune system cells to target the cancer.

The drug has been available on the NHS for...

To continue reading

Request your trial

VLEX uses login cookies to provide you with a better browsing experience. If you click on 'Accept' or continue browsing this site we consider that you accept our cookie policy. ACCEPT